Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ray-Coquard

Showing results (241-250 of 550) with videos related to

Pageof 55
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|May 8, 2023
Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA SubstudyJustine Lequesne, Florence Joly, Julien Peron, et al.
Clinical Sarcoma Research|May 12, 2017
Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's)Sarah Bétrian, Christophe Bergeron, Jean-Yves Blay, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|May 22, 2025
Pierre Yves Meunier, Karfala Maiga, Denis Maillet, et al.
Cancer|October 16, 2013
Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: results of a randomized, double-blind, phase 2, parallel-arm studyWilliam P Tew, Nicoletta Colombo, Isabelle Ray-Coquard, et al.
Bulletin Du Cancer|December 6, 2006
[Neoadjuvant chemotherapy in sarcoma]Jean-Yves Blay, Sylvie Bonvalot, Jérôme Fayette, et al.
AJR. American Journal of Roentgenology|September 29, 2020
Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma GroupAmandine Crombé, Michèle Kind, Isabelle Ray-Coquard, et al.
Expert Opinion on Pharmacotherapy|April 22, 2008
Imatinib mesilate for the treatment of gastrointestinal stromal tumourPhilippe A Cassier, Armelle Dufresne, Samia Arifi, et al.
BMC Cancer|March 7, 2020
Incidence and time trends of sarcoma (2000-2013): results from the French network of cancer registries (FRANCIM)Brice Amadeo, Nicolas Penel, Jean-Michel Coindre, et al.
Frontiers in Oncology|September 26, 2019
Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 ConsortiumIsabelle Ray-Coquard, Ioana Braicu, Regina Berger, et al.
Cancers|September 16, 2020
Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural HistoryMehdi Brahmi, Tatiana Franceschi, Isabelle Treilleux, et al.
Pageof 55

Showing results (241-250 of 550) with videos related to

Sort By:
Pageof 55
Journal of the National Comprehensive Cancer Network : JNCCN|May 8, 2023
Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA SubstudyJustine Lequesne, Florence Joly, Julien Peron, et al.
Clinical Sarcoma Research|May 12, 2017
Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's)Sarah Bétrian, Christophe Bergeron, Jean-Yves Blay, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|May 22, 2025
Pierre Yves Meunier, Karfala Maiga, Denis Maillet, et al.
Cancer|October 16, 2013
Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: results of a randomized, double-blind, phase 2, parallel-arm studyWilliam P Tew, Nicoletta Colombo, Isabelle Ray-Coquard, et al.
Bulletin Du Cancer|December 6, 2006
[Neoadjuvant chemotherapy in sarcoma]Jean-Yves Blay, Sylvie Bonvalot, Jérôme Fayette, et al.
AJR. American Journal of Roentgenology|September 29, 2020
Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma GroupAmandine Crombé, Michèle Kind, Isabelle Ray-Coquard, et al.
Expert Opinion on Pharmacotherapy|April 22, 2008
Imatinib mesilate for the treatment of gastrointestinal stromal tumourPhilippe A Cassier, Armelle Dufresne, Samia Arifi, et al.
BMC Cancer|March 7, 2020
Incidence and time trends of sarcoma (2000-2013): results from the French network of cancer registries (FRANCIM)Brice Amadeo, Nicolas Penel, Jean-Michel Coindre, et al.
Frontiers in Oncology|September 26, 2019
Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 ConsortiumIsabelle Ray-Coquard, Ioana Braicu, Regina Berger, et al.
Cancers|September 16, 2020
Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural HistoryMehdi Brahmi, Tatiana Franceschi, Isabelle Treilleux, et al.
Pageof 55